# FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas

> **NCT03730077** · PHASE1 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 5 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** 18F-FMISO

## Key facts

- **NCT ID:** NCT03730077
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-01
- **Primary completion:** 2021-02-18
- **Final completion:** 2021-02-18
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** PI Left Institution
- **Last updated:** 2021-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03730077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03730077, "FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03730077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*